<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of the Russian academy of medical sciences</journal-id><journal-title-group><journal-title xml:lang="en">Annals of the Russian academy of medical sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российской академии медицинских наук</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-6047</issn><issn publication-format="electronic">2414-3545</issn><publisher><publisher-name xml:lang="en">"Paediatrician" Publishers LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">61</article-id><article-id pub-id-type="doi">10.15690/vramn.v70i2.1318</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>SHORT MESSAGES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">HYDROGEN SULFIDE AS A THIRD ESSENTIAL GAS MOLECULE IN LIVING TISSUES</article-title><trans-title-group xml:lang="ru"><trans-title>СЕРОВОДОРОД КАК ТРЕТЬЯ ЭССЕНЦИАЛЬНАЯ ГАЗОВАЯ МОЛЕКУЛА ЖИВЫХ ТКАНЕЙ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kolesnikov</surname><given-names>S. I.</given-names></name><name xml:lang="ru"><surname>Колесников</surname><given-names>С. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>доктор медицинских наук, академик РАН, главный научный сотрудник НЦ ПЗСРЧ, заслуженный деятель науки РФАдрес: 664003, Иркутск, ул. Тимирязева, д. 16, тел.: +7 (3952) 20-76 36</p></bio><email>sikolesnikov2012@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Vlasov</surname><given-names>B. Ya.</given-names></name><name xml:lang="ru"><surname>Власов</surname><given-names>Б. Я.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>доктор медицинских наук, профессор, старший научный сотрудник лаборатории физиологии и патологии эндокринной системы НЦ ПЗСРЧАдрес: 664003, Иркутск, ул. Тимирязева, д. 16, тел.: +7 (3952) 20-76-36, 20-73-67</p></bio><email>vlasov.vlabor@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kolesnikova</surname><given-names>L. I.</given-names></name><name xml:lang="ru"><surname>Колесникова</surname><given-names>Л. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>доктор медицинских наук, член-корреспондент РАН, профессор, директор НЦ ПЗСРЧАдрес: 664003, Иркутск, ул. Тимирязева, д. 16, тел.: +7 (3952) 20-76-36</p></bio><email>iphr@sbamsr.irk.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Scientific Center of the Problems of Family Health and Human Reproduction, Irkutsk, Russian Federation</institution></aff><aff><institution xml:lang="ru">Научный центр проблем здоровья семьи и репродукции человека, Иркутск, Российская Федерация</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-04-08" publication-format="electronic"><day>08</day><month>04</month><year>2015</year></pub-date><volume>70</volume><issue>2</issue><issue-title xml:lang="en">Vestnik Rossiiskoi akademii medetsinskikh nauk / Annals of the Russian academy of medical sciences</issue-title><issue-title xml:lang="ru">Вестник Российской академии медицинских наук</issue-title><fpage>237</fpage><lpage>241</lpage><history><date date-type="received" iso-8601-date="2015-08-07"><day>07</day><month>08</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, "Paediatrician" Publishers LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, Издательство "Педиатръ"</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">"Paediatrician" Publishers LLC</copyright-holder><copyright-holder xml:lang="ru">Издательство "Педиатръ"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2016-04-08"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://vestnikramn.spr-journal.ru/jour/about/submissions</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikramn.spr-journal.ru/jour/article/view/61">https://vestnikramn.spr-journal.ru/jour/article/view/61</self-uri><abstract xml:lang="en"><p><italic>The data of foreign studies over the last 15 years devoted to endogenous synthesis and biological role of hydrogen sulfide in micromolar quantities which complemented the already two well-known gas transmitters — OH and NO are presented in this review. Despite the short period since the physiological properties of hydrogen sulfide were opened (about 20 years) it was found that this gas transmitter plays a key role in the regulation of nerve (neural signal transmission), cardiovascular (relaxation of smooth muscles), immune (anti-inflammatory and cytoprotective agent) sensory, gastrointestinal (output of insulin) systems and in the metabolism of various organs. Currently the role of </italic><italic>H<sub>2</sub>S</italic><italic> in the pathogenesis of different diseases, neurodegenerative diseases, diabetes, heart failure) is being studying. The developments of drugs that act as either exogenous donors</italic><italic> H<sub>2</sub>S or</italic><italic> blockers of the biosynthesis of </italic><italic>H<sub>2</sub>S</italic><italic> are promising. With consideration the fact that </italic><italic>H<sub>2</sub>S</italic><italic> is a representative of non-synaptic way of intercellular communication based on diffusion of molecules of inorganic compounds in the intercellular space in all directions and effect on distant from their place of formation non- synaptic receptors it is suggested to use exogenous </italic><italic>H<sub>2</sub>S</italic><italic> in strict proportion for the treatment of a number of human diseases.</italic></p><p> </p></abstract><trans-abstract xml:lang="ru"><p><italic>Представлены данные зарубежных исследователей за последние 15 лет, посвященные эндогенному биосинтезу и биологической роли сероводорода в микромолярных количествах, который дополнил уже два известных газотрансмиттера — ОН и </italic><italic>NO</italic><italic>. Несмотря на незначительный период со дня открытия физиологических свойств сероводорода (около 20 лет), установлено, что этот газотрансмиттер играет ключевую роль в регуляции нервной</italic><italic> (нейронная передача сигнала), сердечно-сосудистой (расслабление гладких мышц), иммунной (противовоспалительный и цитопротекторный агент) сенсорной, желудочно-кишечной (выход инсулина) системы, а также в метаболизме различных органов. В настоящее время ведется изучение роли H<sub>2</sub>S в патогенезе различных заболеваний (нейродегенеративные болезни, сахарный диабет, сердечная недостаточность). Перспективными являются разработки по созданию препаратов, которые выступают либо в качестве экзогенных доноров H<sub>2</sub>S, либо в роли блокаторов биосинтеза H<sub>2</sub>S. С учетом того факта, что H<sub>2</sub>S является представителем несинаптического способа межклеточной коммуникации, основанного на диффузии молекул неорганических соединений по межклеточному пространству во всех направлениях и действии на отдаленные от их места образования несинаптические рецепторы, предлагается строго дозированно использовать и экзогенный H<sub>2</sub>S для лечения ряда заболеваний человека.</italic></p><p> </p></trans-abstract><kwd-group xml:lang="en"><kwd>gas transmitters</kwd><kwd>hydrogen sulfide</kwd><kwd>biological effects</kwd><kwd>the prospects for medical application</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>газовые трансмиттеры</kwd><kwd>сероводород</kwd><kwd>биологические эффекты</kwd><kwd>перспективы лечебного применения</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1.	Wang R. Signal transduction and the gasotransmitters: NO, CO and H2S in biology and мedicine. Totowa: Humana Press. 2004. 392 p.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2.	Tripatara P., Patel N.S., Collino M., Gallicchio M., Kieswich J., Castiglia S. Generation of endogenous hydrogen sulfide by cystathionine gammalyase limits renal ischemia/reperfusion injury and dysfunction. Lab. Invest. 2008; 88: 1038–1048.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3.	Carsten A.W. Hydrogen sulfide: a new gaseous signal molecule and blood pressure regulator J. Nephrol. 2009; 22: 173–176.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4.	Fiorucci S., Distrutti E., Cirino G., Wallace J.L. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. J. Gastroenterol. 2006; 131: 259–271.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5.	Abe K., Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J. Neurosci. 1996; 16: 1066–1071.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6.	Kimura Y., Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 2004; 18: 1165–1167.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7.	Mathaia J.C., Missnerb A., Ku P. et al. No facilitator required for membrane transport of hydrogen sulfide. Proc. Natl. Acad. Sci. U.S.A. 2009; 106: 16633–16638.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8.	Li L., Moore P.K. Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends Pharmacol. Sci. 2008; 29: 84–90.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9.	Reiffenstein R.J., Hulbert W.C. Toxicology of hydrogen sulfide. Annu. Rev. Pharmacol. Toxicol. 1992; 32: 109–134.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10.	Lowicka E., Beltowski J. Hydrogen sulfide — the third gas of interest for pharmacologists. Pharmacol. Reports. 2007; 59: 4–24.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11.	Wagner C.A. Hydrogen sulfide: a new gaseous signal molecula and blood pressure regulator J. Nephrol. 2009; 22: 173–176.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12.	Kamoun P. Endogenous production of hydrogen sulfide in mammals. Amino Aсids. 2004; 26: 243–254.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13.	Stipanuk M.H., Beck P.W. Characterization of the enzymic capacity for cysteine desulphydration in liver and kidney of the rat. Biochem. J. 1982; 206: 267–277.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14.	Shibuya N., Milkanai Y., Kimura Y., Nagahara N., Kimura H. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J. Biochem. Adv. Access. 2009; 146: 623–626.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15.	Whiteman M., Armstrong J.S., Chu S.H., Jia–Ling S., Wong B.S., Cheung N.S., Halliwell B. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite «scavenger»? J. Neurochem. 2004; 90: 765–768.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16.	Yan S.K., Chang T., Wang H., Wu L., Wang R., Meng Q.H. Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 2006; 361: 485–491.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17.	Rinaldi L., Gobbi G., Pambianco M., Micheloni C., Mirandola P., Vitale M. Hydrogen sulfide prevents apoptosis of human PMN via inhibition of p38 and caspase 3. Lab. Invest. 2006; 86: 391–397.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18.	Qu K., Lee S. W., Bian J.S., Low, C.M.; Wong, P.T. Hydrogen sulfide: neurochemistry and neurobiology. Neurochem. Int. 2008; 52: 155–165.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19.	Kimura H., Nagai Y., Umemura K., Kimura Y. Physiological roles of hydrogen sulfide: Synaptic modulation, neuroprotection, and smooth muscle relaxation. Antioxid. Redox. Signal. 2005; 7: 795–803.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20.	Antonini E., Brunori M. Hemoglobin and myoglobin in their reactions with ligands. Amsterdam: North-Holland Publishing. 1971. 393 р.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21.	Yonetani T., Tsuneshige A., Zhou Y., Chen X. Electron paramagnetic resonance and oxygen binding studies of anitrosyl hemoglobin: a novel oxygen carrier having NO assisted allosteric functions. J. Biol. Chem. 1998; 273: 20323–20333.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22.	Mustafa A.K., Gadalla M.M., Snyder S.H. Signaling by gasotransmitters. Sci. Signal. 2009; 2: 2.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23.	Hill B.C., Woon T.C., Nicholls P., Peterson J., Greenwood C., Thomson A.J. Interactions of sulphide and other ligands with cytochrome c oxidase. An electron paramagnetic resonance study. Biochem. J. 1984; 224: 591–600.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>24.	Yang G., Cao K., Wu L., Wang R. Cystathionine γ-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/ WAK–1. J. Biol. Chem.2004; 279: 49199–49205.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>25.	Beltowski J. Hydrogen sulfide as a biologically active mediator in the cardiovascular system. Postepy. Hig. Med. Dosw. 2004; 58: 285–291.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>26.	Geng B., Yang J., Qi Y., Zhao J., Peng Y., Du J., Tang C. H2S generated by heart in rat and its effects on cardiac function. Biochem. Biophys. Res. Commun. 2004; 313: 362–368.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>27.	Smith R.P. A short history of hydrogen sulfide. American Scientist. 2010; 98: 6.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>28.	Skovgaard N., Gouliaev A., Aalling M., Simonsen U. The Role of Endogenous H2S in Cardiovascular Physiology. Curr. Pharm. Biotechnol. 2011; 12: 1385–1393.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>29.	Wang R. Hydrogen sulfide: the third gasotransmitter in biology and medicine. Antioxid. Redox. Signal. 2010; 12: 1061–1064.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>30.	John L.W. Physiological and pathophysiological roles of hydrogen sulfide in the gastrointestinal tract. Antiox. Redox. Signal. 2010; 12: 1125–1133.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>31.	Wang R. Two’s company, three’s a crowd: can H2S be the third endogenous gaseous transmitter? FASEB J. 2002; 16: 1792–1798.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>32.	Jang G., Wu L., Liang W., Wang R. Direct stimulation of K (ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol. Pharmacol. 2005; 68: 1757–1817.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>33.	Zhao W., Wang R. H2S induced vasorelaxation and underlying cellular and molecular mechanisms. Am. J. Physiol. Heart. Circ. Physiol. 2002; 283: 474–480.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>34.	Zhao W., Zhang J., Lu Y., Wang R. The vasorelaxant effect of H2S as a novel endogenous gaseous K (ATP) channel opener. EMBO J. 2001; 20: 6008–6016.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>35.	Lavu M., Bhushan S., Lefler D.J. Hydrogen sulfide-mediated cardioprotection: mechanisms and therapeutic protection. Clin. Sci. 2011; 120: 219–229.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>36.	Nakao A., Sugimoto R., Billiar T. R., McCurry K. R. Therapeutic antioxidant medical gas. J. Clin. Biochem. Nutr. 2009; 44: 1–13.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>37.	Wei G., Ze-yu C., Yi–zhun Z. Hydrogen sulfide and translational medicine. Acta Pharmacol. Sinica. 2013; 34: 1284–1291.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>38.	Warenycia M.W., Steele J.A., Karpinski E., Reiffenstein R.J. Hydrogen sulfide in combination with taurine or cysteic acid reversibly abolishes sodium currents in neuroblastoma cells. Neurotoxicology. 1989; 10: 191–199.</mixed-citation></ref></ref-list></back></article>
